Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2026-03-31)

USD 18.52+1.37%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

5.00 2 votes No rating yet

NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo K.K. is a Japanese pharmaceutical manufacturer that develops, produces and markets medicines and related chemical intermediates for healthcare markets, supplying hospitals, pharmacies and distributors at home and abroad. Its business combines research and formulation work with commercial manufacturing—covering active pharmaceutical ingredient production, finished‑dose formulation, quality control and regulatory compliance—and it also provides contract manufacturing and outsourcing services to other drugmakers. The company’s product mix spans prescription (ethical) medicines, consumer health/OTC products and bulk pharmaceutical ingredients, with operations organized to support manufacturing scale, supply‑chain reliability and customer distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

24.5%1Y

12.4%3Y

1.42%5Y

Performance

20.5%1Y

18.8%3Y

19.7%5Y

Volatility

58508 M

Market cap (USD)

4,945,244

Daily traded volume (Shares)

13.25 / 13.155

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

5.00

2 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Adam Hakimi Bin Hasni

United Kingdom, 04 Nov 2025

A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan

sofia nava

Switzerland, 29 Oct 2025

.

EQUITIES OF THE SAME SECTOR

Orion Oyj

Orion Oyj Valor: 2553360

Annual Return

-50%0%+50%

Risk level

110

2.21%EUR 69.50

Beiersdorf AG

Beiersdorf AG Valor: 324660

Annual Return

-50%0%+50%

Risk level

110

0.21%EUR 76.58

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG Valor: 1055489

Annual Return

-50%0%+50%

Risk level

110

-0.49%EUR 24.20

Formycon AG

Formycon AG Valor: 12194189

Annual Return

-50%0%+50%

Risk level

110

-0.11%EUR 18.00

RHOEN-KLINIKUM AG

RHOEN-KLINIKUM AG Valor: 341644

Annual Return

-50%0%+50%

Risk level

110

-0.80%EUR 12.40

Draegerwerk AG & Co. KGaA

Draegerwerk AG & Co. KGaA Valor: 330446

Annual Return

-50%0%+50%

Risk level

110

0.33%EUR 90.90

MEDICLIN AG

MEDICLIN AG Valor: 1158721

Annual Return

-50%0%+50%

Risk level

110

-3.98%EUR 3.38

CHAPTERS Group AG

CHAPTERS Group AG Valor: 2175722

Annual Return

-50%0%+50%

Risk level

110

6.45%EUR 33.00

M1 Kliniken AG

M1 Kliniken AG Valor: 29694419

Annual Return

-50%0%+50%

Risk level

110

2.08%EUR 14.72

4basebio PLC

4basebio PLC Valor: 112829117

Annual Return

-50%0%+50%

Risk level

110

-1.62%EUR 5.42

SIX

FactSet

Clearbit

Logos provided by Clearbit